世界卫生组织欧洲区域消除麻疹和风疹的进展与挑战
世界卫生组织欧洲区域在消除麻疹和风疹方面取得稳步进展,2015年超过半数国家中断了这两种疾病的本地传播。但散发性疫情仍在持续,主要影响未接种或接种史不全的青少年和年轻成人,所有国家需改进病例监测、确保疫情记录完整并加强流行病学与实验室数据衔接。
要点
- 2015年欧洲区域超过半数国家中断了麻疹和风疹的本地传播。
- 散发性疫情持续,主要影响未接种或接种史不全的青少年和年轻成人。
- 所有国家需改进麻疹和风疹的病例监测并加强流行病学与实验室数据衔接。
核心结论
- 世界卫生组织欧洲区域在消除麻疹和风疹方面取得稳步进展,2015年超过半数国家中断了这两种疾病的本地传播。
- 剩余 endemic 国家在疾病监测、疫苗接种服务提供和沟通方面的规划性挑战应通过所有利益相关方定期评估策略并探索额外机会来加速当前消除活动。
研究设计与样本
- 欧洲麻疹和风疹消除区域核查委员会于2011年成立,基于各国国家核查委员会每年提交的文件评估麻疹和风疹消除状态。
主要发现
- 世界卫生组织欧洲区域近年来麻疹和风疹病例急剧下降,一些曾经常见的麻疹基因型已不再检出。
- 散发性疫情持续,最近主要影响无疫苗接种史或接种史不全的青少年和年轻成人。
- 2015年超过半数国家中断了麻疹和风疹两种疾病的本地传播。
关键数值与推荐
- 所有成员国在2010年重申消除麻疹和风疹的承诺,并将其作为《2015-2020年欧洲疫苗行动计划》的核心目标。
临床怎么用
- 所有国家需要改进麻疹和风疹的病例监测,确保每起疫情均有记录,并加强流行病学与实验室数据之间的衔接。
- 实现麻疹和风疹含疫苗的高覆盖率需要多部门方法,以解决已识别社区中接种率较低的根源,包括服务提供挑战或关于疫苗接种的流传谣言引起的疫苗安全担忧。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Despite availability of safe and cost-effective vaccines to prevent it, measles remains one of the significant causes of death among children under five years of age globally. The World Health Organization (WHO) European Region has seen a drastic decline in measles and rubella cases in recent years, and a few of the once common measles genotypes are no longer detected. Buoyed by this success, all Member States of the Region reconfirmed their commitment in 2010 to eliminating measles and rubella, and made this a central objective of the European Vaccine Action Plan 2015-2020 (EVAP). Nevertheless, sporadic outbreaks continue, recently affecting primarily adolescents and young adults with no vaccination or an incomplete vaccination history. The European Regional Verification Commission for Measles and Rubella Elimination was established in 2011 to evaluate the status of measles and rubella elimination based on documentation submitted annually by each country's national verification committee. DISCUSSION: Each country's commitment to eliminate measles and rubella is influenced by competing health priorities, and in some cases lack of capacity and resources. All countries need to improve case-base surveillance for both measles and rubella, ensure documentation of each outbreak and strengthen the link between epidemiology and laboratory data. Achieving high coverage with measles- and rubella-containing vaccines will require a multisectoral approach to address the root causes of lower uptake in identified communities including service delivery challenges or vaccine safety concerns caused by circulating myths about vaccination. CONCLUSIONS: The WHO European Region has made steady progress towards eliminating measles and rubella and over half of the countries interrupted endemic transmission of both diseases by 2015. The programmatic challenges in disease surveillance, vaccination service delivery and communication in the remaining endemic countries should be addressed through periodic evaluation of the strategies by all stakeholders and exploring additional opportunities to accelerate the ongoing elimination activities.
引用
- Datta SS, O'Connor PM, Jankovic D, et al. Progress and challenges in measles and rubella elimination in the WHO European Region. Vaccine. 2017. PMID: 28651838. doi:10.1016/j.vaccine.2017.06.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。